Post office box

If You Purchased a Huda Beauty Neon Obsessions Pressed Pigment Palette, You May Be Eligible for a Cash Refund up to $87 With Proof of Purchase from a Class Action Settlement

Thursday, October 14, 2021 - 2:00pm

A Proposed Settlement has been reached in a class action lawsuit.Purchasers of Huda Beauty Neon Obsessions makeup palettes sued the distributors, HB USA Holdings, Inc. dba Huda Beauty, alleging violations of laws relating to the sale of the Huda Beauty Neon Obsessions Pressed Pigment Products (the "Products").

Key Points: 
  • A Proposed Settlement has been reached in a class action lawsuit.Purchasers of Huda Beauty Neon Obsessions makeup palettes sued the distributors, HB USA Holdings, Inc. dba Huda Beauty, alleging violations of laws relating to the sale of the Huda Beauty Neon Obsessions Pressed Pigment Products (the "Products").
  • If you don't submit a timely Claim Form and don't exclude yourself from the settlement, you will be bound by the settlement and will not receive a Cash Payment.
  • You Can Object to the Settlement.You can ask the Court to deny approval by objecting with the Court.
  • Class members who are unable to provide valid Proof of Purchase shall be eligible to submit a claim for payment of a total of Ten U.S.

EQS-News: Bellevue Asset Management launches Bellevue Global Income (Lux) Fund

Monday, October 11, 2021 - 7:03am

Bellevue is a specialized asset manager listed on the SIX Swiss Exchange with core competencies covering healthcare strategies, entrepreneur strategies, alternative and traditional investment strategies.

Key Points: 
  • Bellevue is a specialized asset manager listed on the SIX Swiss Exchange with core competencies covering healthcare strategies, entrepreneur strategies, alternative and traditional investment strategies.
  • Established in 1993, Bellevue, a House of Investment Ideas staffed by 100 professionals, generates attractive investment returns and creates value added for clients and shareholders alike.
  • Bellevue Funds (Lux) SICAV is registered in the CNMV registry of foreign collective investment schemes distributed in Spain, under registration number 938.
  • With respect to fund units distributed in or from Switzerland, the place of performance and jurisdiction is established at the registered office of the representative.

Bernstein Litowitz Berger & Grossmann LLP Announce a Proposed Settlement in the Symantec Corporation Securities Litigation

Friday, October 8, 2021 - 3:00pm

Any fees and expenses awarded by the Court will be paid from the Settlement Fund.

Key Points: 
  • Any fees and expenses awarded by the Court will be paid from the Settlement Fund.
  • Copies of the Settlement Notice and Claim Form can also be downloaded from the website for the Action, www.SymantecSecuritiesLitigation.com .
  • The Settlement website, www.SymantecSecuritiesLitigation.com , will be updated to inform Class Members of the approval of the Settlement, if and when that occurs.
  • All questions about this notice, the proposed Settlement, or your eligibility to participate in the Settlement should be directed the Claims Administrator or Class Counsel.

EQS-News: CHRONEXT AG: CHRONEXT AG postpones contemplated IPO

Wednesday, October 6, 2021 - 11:05am

A decision to invest in securities of CHRONEXT AG should be based exclusively on the prospectus published by CHRONEXT AG (the "Company") for such purpose.

Key Points: 
  • A decision to invest in securities of CHRONEXT AG should be based exclusively on the prospectus published by CHRONEXT AG (the "Company") for such purpose.
  • Copies of such prospectus (and any supplements thereto) are available free of charge from UBS AG, Swiss Prospectus Switzerland, P.O.
  • CHRONEXT AG assumes no responsibility to up-date forward-looking statements or to adapt them to future events or developments.
  • Except as required by applicable law, CHRONEXT AG has no intention or obligation to update, keep updated or revise this publication or any parts thereof following the date hereof.

Appili Therapeutics and AiPharma Announce Strategic Alliance and Equity Transaction

Wednesday, September 29, 2021 - 12:39pm

Appili and AiPharma entered into a strategic equity transaction (the Definitive Agreement) to establish minority positions in each others businesses, further align their goals and participate in each others respective economic interests.

Key Points: 
  • Appili and AiPharma entered into a strategic equity transaction (the Definitive Agreement) to establish minority positions in each others businesses, further align their goals and participate in each others respective economic interests.
  • Assuming no further equity issuances, it is expected that AiPharma will hold approximately 19.4% of the issued and outstanding Appili Shares immediately following closing.
  • Immediately prior to the Investment, AiPharma, its affiliates and joint actors owned no voting or equity securities in the capital of Appili.
  • Upon closing of the Investment, AiPharma and its affiliates will own 15,079,709 Appili Shares, representing approximately 19.4% of the currently outstanding Appili Shares, on a non-diluted basis.

EQS-News: CHRONEXT AG: sets price range at CHF 16 to CHF 21 per share

Tuesday, September 28, 2021 - 7:00am

Any investment decisions with respect to any securities should not be made based on this advertisement.

Key Points: 
  • Any investment decisions with respect to any securities should not be made based on this advertisement.
  • A decision to invest in securities of CHRONEXT AG should be based exclusively on the prospectus published by CHRONEXT AG (the "Company") for such purpose.
  • Copies of such prospectus (and any supplements thereto) are available free of charge from UBS AG, Swiss Prospectus Switzerland, P.O.
  • CHRONEXT AG assumes no responsibility to up-date forward-looking statements or to adapt them to future events or developments.

Notice of Proposed Class Action Settlement Involving all Persons and Entities that Purchased or Otherwise Acquired Eagle Bancorp, Inc. Securities

Monday, September 27, 2021 - 2:17pm

Unless otherwise defined herein, capitalized words used in this Summary Notice are defined in the Stipulation and Agreement of Settlement dated June28, 2021 ("Stipulation"), which is available at www.EagleSecuritiesSettlement.com .

Key Points: 
  • Unless otherwise defined herein, capitalized words used in this Summary Notice are defined in the Stipulation and Agreement of Settlement dated June28, 2021 ("Stipulation"), which is available at www.EagleSecuritiesSettlement.com .
  • YOU ARE ALSO NOTIFIED that Plaintiffs in the Action have reached a proposed settlement of the Action for $7,500,000 in cash (the "Settlement"), that, if approved, will resolve all claims in the Action.
  • Copies of the Notice and Claim Form can also be downloaded from the website maintained by the Claims Administrator, www.EagleSecuritiesSettlement.com .
  • All questions about this notice, the proposed Settlement, or your eligibility to participate in the Settlement should be directed to Lead Counsel or the Claims Administrator.

Tesla Announces Updates to 2021 Annual Meeting of Stockholders

Saturday, September 25, 2021 - 1:52am

Tesla, Inc. today announced updates to its 2021 Annual Meeting of Stockholders (the 2021 Annual Meeting).

Key Points: 
  • Tesla, Inc. today announced updates to its 2021 Annual Meeting of Stockholders (the 2021 Annual Meeting).
  • Live video webcasts of the 2021 Annual Meeting event will be accessible to the general public at www.tesla.com/2021shareholdermeeting .
  • To accommodate ongoing public health requirements and travel considerations, Tesla is providing any stockholder as of August 9, 2021 the means to join the 2021 Annual Meeting virtually at https://meetnow.global/MVA22YQ .
  • Proxy cards, voting instruction forms and Notices of Internet Availability for the 2021 Annual Meeting scheduled for October 7, 2021 that were previously distributed will not be updated to reflect the change in meeting format, and may continue to be used to vote shares in connection with the 2021 Annual Meeting.

Bernstein Litowitz Berger & Grossmann LLP and Carella, Byrne, Cecchi, Olstein, Brody & Agnello, P.C. Announce Proposed Settlements for Third-Party Payors That Purchased or Paid for Valeant-Branded Drugs

Wednesday, September 22, 2021 - 7:00pm

16-3087-(MAS)(LHG), is pending in the United States District Court for the District of New Jersey (the "Court").

Key Points: 
  • 16-3087-(MAS)(LHG), is pending in the United States District Court for the District of New Jersey (the "Court").
  • Excluded from the Settlement Class are Pharmacy Benefit Managers, Defendants, Defendants' successors and assigns, and any entity in which any Defendant has or had a controlling interest.
  • Copies of the Notice and Claim Form can also be downloaded from the website maintained by the Claims Administrator, www.ValeantTPPSettlement.com .
  • Object to one or both of the Settlements, the proposed Plan of Allocation, and/or counsel's request for attorneys' fees and expenses.

If You Purchased Coppertone Sunscreen with "Mineral-Based" on the Label, in Various Sizes and Forms, including COPPERTONE WATER BABIES PURE & SIMPLE, KIDS TEAR FREE, AND SPORT FACE (collectively, "PRODUCTS" or "QUALIFYING PRODUCTS"), You May be Eligible t

Monday, September 20, 2021 - 2:00pm

A class action lawsuit pending in the U.S. District Court for the Northern District of California called Prescott v. Bayer HealthCare LLC, Case No.

Key Points: 
  • A class action lawsuit pending in the U.S. District Court for the Northern District of California called Prescott v. Bayer HealthCare LLC, Case No.
  • The Court did not rule in favor of the Plaintiffs who filed the Litigation or the Defendants.
  • If you are a member of the Class, you have three options:
    1.You Can Make a Claim.
  • You cannot ask the Court to order a larger settlement; the Court can only approve or deny the settlement.